Skip to main content
logo
Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
255.00
-6.08 (-2.33%)
At close: Mar 11, 2026, 4:00 PM EDT
253.60
-1.40 (-0.55%)
After-hours: Mar 11, 2026, 7:55 PM EDT

Krystal Biotech Revenue

In the year 2025, Krystal Biotech had annual revenue of $389.13M with 33.94% growth. Krystal Biotech had revenue of $107.11M in the quarter ending December 31, 2025, with 17.52% growth.

Revenue (ttm)
$389.13M
Revenue Growth
+33.94%
P/S Ratio
19.16
Revenue / Employee
$1,319,085
Employees
295
Market Cap
7.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025389.13M98.62M33.94%
Dec 31, 2024290.52M239.82M473.02%
Dec 31, 202350.70M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Halozyme Therapeutics1.40B
Arrowhead Pharmaceuticals1.09B
Axsome Therapeutics638.50M
Cytokinetics88.04M
Kymera Therapeutics39.21M
Arcellx22.29M
Praxis Precision Medicines7.46M
ABIVAX Société Anonyme6.23M
Revenue Rankings

KRYS News

More News